Yokohama Biopharmaceutical R & D Center (YBIRD)

- R & D facilities of biopharmaceuticals -

Yokohama Biopharmaceutical Research and Development Center enables to manufacture genetically modified protein study drugs (non-sterile drug substances) by GMP standards. The center has production technology laboratory and GMP manufacturing facilities (duel lines for animal cells and microbes), available for most types of medium.

Manufacturing scale: Animal cell fermentation device 500 liter, Microbe fermentation device 300 liter

Culture room for microbe cells

Culture room for microbe cells

Protein purification room

Protein purification room

From early stage detection to various types of cooperation (co-research, contracted research, contracted test, technical evaluation tests and others), the Foundation supports through YBIRD facilities, manufacturing process researches and production relating with manufacture of study drugs or non-clinical study drugs indispensable for biopharmaceutical drug discovery. Also the Foundation supports biopharmaceutical manufacturing technologies (production, refinement, monitoring and others). Furthermore, the Foundation focuses the development of biotechnology related human resources via technical training programs, lectures and others. Guided facility tours are available, please contact us anytime soon.
(email address: gmp@kihara.or.jp)

YBIRD started its operation April 2011, as the first Good Manufacturing Practices Standards facility of biopharmaceuticals run by public organizations in Japan.

pamphlet(pdf)

*Good Manufacturing Practice Standards is quality control standards and manufacturing management of quasi-drugs and pharmaceutical products by the Ministry of Health, Labor and Welfare.